• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>XenoPort

XenoPort

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review Report H2 2016 - Research and Markets

    Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review Report H2 2016 - Research and Markets

  2. Flying High in the Sky, Looking for Opportunities in 2015

    XenoPort hopes to gain approval for XP13512 after the success of its Phase III trials.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.